I’m finally beginning to get back in the swing of blogging, after a long hiatus getting ramped up at my new job as HL7 CTO. Here are a few thoughts on the HL7 FHIR standard, and how it may help reimagine clinical research in the Biopharmaceutical industry.
Reimagining Research 